Shares of Prana Biotechnology Ltd. (NASDAQ: PRAN) soared as much as much as 6% on Tuesday on speculation that the company could be a takeover target. Prana Biotechnology Limited engages in the research and development of therapeutic drugs for neurological diseases in Australia. The company primarily focuses on the Alzheimer's, Parkinson's, and Huntington's diseases, as well as various age-related degenerative disorders. Stay tuned for more.
Full Disclosue: None.
